Atlas Trials

Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Clinical trial NCT06861010 · RECRUITING

Trial details

NCT number
NCT06861010
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Diseases
Start date
2025-03-01
Primary completion
2026-12-20
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.